Analysts: Opexa Therapeutics Inc (OPXA.W)

Consensus Recommendations

Consensus Recommendation	Next Earnings (approx.)	Company Fiscal Year End Month	Last Updated

Analyst Recommendations and Revisions

No analyst recommendations and revisions data available;

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)

	# of Estimates	Mean	High	Low	1 Year Ago

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)

Estimates vs Actual	Estimate	Actual	Difference	Surprise %
SALES (in millions)
Quarter Ending Jun-11	0.00	0.00	0.00	0.00
Quarter Ending Mar-11	0.00	0.00	0.00	0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)

	Current	1 Week Ago	1 Month Ago	2 Month Ago	1 Year Ago

Estimates Revisions Summary

	Last Week		Last 4 Weeks
Number Of Revisions:	Up	Down	Up	Down
Revenue
Earnings

Earnings vs. Estimates

» More Financials

Opexa Therapeutics Inc News

» More OPXA.W News

Analyst Research Reports

Report Title	Price
OPEXA THERAPEUTICS INC (OPXA) 12-months forecast Provider: Pechala's Reports	$15.00 Buy
Opexa Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
TheStreet.com Ratings Stock Report For: OPEXA THERAPEUTICS INC (OPXA) Provider: TheStreet.com Ratings	$10.00 Buy
Opexa Therapeutics, Inc. (OPXA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Provider: GlobalData	$250.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.